Hospital Británico de Buenos Aires
About Hospital Británico de Buenos Aires
Hospital Británico de Buenos Aires is a hospital in Buenos Aires, Argentina.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
15
Pfizer
11
Janssen Research & Development, LLC
4
Merck Sharp & Dohme LLC
4
Actelion
3
Boehringer Ingelheim
3
Gilead Sciences
3
United Therapeutics
3
Genfit
2
Hospital Britanico
2
Intercept Pharmaceuticals
2
Clinical Trials at Hospital Británico de Buenos Aires
During the past decade, Hospital Británico de Buenos Aires conducted 51 clinical trials. In the 10-year time frame, 51 clinical trials started and 27 clinical trials were completed, i.e. on
average, 52.9% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 16 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer
2001-10-29
2009-02-10
Completed
569
OSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
2001-11-01
2004-01-30
Completed
731
OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.
2001-11-29
2004-01-15
Completed
569
A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
2006-01-01
2014-11-01
Completed
1,145
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
2006-01-18
2015-08-06
Completed
571
DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant Hypertension
2006-06-01
2009-01-01
Completed
352
DORADO-EX: Long-Term Safety Extension Study to the Phase 3 DORADO Study (Protocol DAR-311) of Darusentan in Resistant Hypertension
2006-09-01
2010-04-01
Terminated
282
Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy
1996-01-01
2005-12-01
Completed
20
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hospital Británico de Buenos Aires" #1 sponsor was "Hoffmann-La Roche" with 15 trials, followed by "Pfizer" with 11 trials
sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored, "Merck Sharp & Dohme LLC" with 4 trials sponsored and "Actelion"
with 4 trials sponsored. Other sponsors include 45 different institutions and
companies that sponsored additional 43 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Británico de Buenos Aires"
#1 collaborator was "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Actoverco" with 1 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator and "Applied Health Research Centre" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were
collaborators in the rest 31 trials.
Clinical Trials Conditions at Hospital Británico de Buenos Aires
According to Clinical.Site data, the most researched conditions in "Hospital Británico de Buenos Aires" are
"Colitis, Ulcerative" (4 trials), "Hypertension" (4 trials), "Pulmonary Hypertension" (4 trials), "Rheumatoid Arthritis" (4 trials) and "Pancreatic Cancer" (3 trials). Many other conditions were trialed in "Hospital Británico de Buenos Aires" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Británico de Buenos Aires
Most popular intervention types in "Hospital Británico de Buenos Aires" are "Drug" (73 trials), "Biological" (11 trials), "Other" (8 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (31 trials), "Atezolizumab" (6 trials), "Paclitaxel" (5 trials), "Carboplatin" (4 trials) and "Pembrolizumab" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Británico de Buenos Aires
The vast majority of trials in "Hospital Británico de Buenos Aires" are
79 trials for "All" genders, 5 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at Hospital Británico de Buenos Aires
Currently, there are NaN active trials in "Hospital Británico de Buenos Aires".
undefined are not yet recruiting,
14 are recruiting,
12 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 38 completed trials in Hospital Británico de Buenos Aires,
undefined suspended trials,
and 20 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Británico de Buenos Aires, 2 "Phase 1"
clinical trials were conducted, 19 "Phase 2" clinical
trials and 54 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 5 trials, and there were
also 5 trials that are defined as “Not Applicable".
Departments of Hospital Británico de Buenos Aires
Hospital Británico de Buenos Aires has several departments that took part in Clinical trials: "Hospital Britanico; Oncologia" - 4 trials, "Hospital Britanico; Haematology" - 2 trials
Departments List
Name
City
Trials